|
|||||
|
|

Agricultural supply chain giant Archer-Daniels-Midland (NYSE:ADM) fell short of the markets revenue expectations in Q4 CY2025, with sales falling 13.7% year on year to $18.56 billion. Its non-GAAP profit of $0.87 per share was 9.2% above analysts’ consensus estimates.
Is now the time to buy ADM? Find out in our full research report (it’s free for active Edge members).
Archer-Daniels-Midland faced a challenging fourth quarter, with management attributing the decline in performance to weak global agricultural trade, lower North American exports, and persistent softness in packaged food demand. CEO Juan Luciano highlighted operational improvements, such as record crush volumes in South America and enhanced manufacturing efficiencies, but acknowledged that these were offset by adverse market dynamics and reduced insurance proceeds. Luciano noted, "Our operating environment throughout 2025 was challenging," and stressed the company’s focus on cost controls, portfolio optimization, and cash flow generation in response to these headwinds.
Looking forward, management’s guidance emphasizes the importance of U.S. biofuel policy clarity and strengthening global trade as primary drivers of Archer-Daniels-Midland’s 2026 outlook. Luciano stated that the timing of regulatory decisions on biofuels will be critical, explaining, “The earlier we receive policy clarity, the larger the opportunity to take advantage of what we expect will be an increasingly more constructive operating environment.” The company is also banking on continued growth in its nutrition segment, improvements in specialty ingredients, and recovering demand for ethanol, while remaining cautious about ongoing cost pressures and evolving consumer trends.
Management pointed to a combination of operational initiatives and external market forces as key influences on quarterly performance, while ongoing portfolio optimization and cost savings efforts were highlighted as central to ADM’s long-term strategy.
ADM’s outlook for 2026 centers on expected improvements in global trade and biofuel policy, as well as continued growth in its nutrition and ethanol businesses.
In the coming quarters, our team will focus on (1) the timing and impact of U.S. biofuel policy decisions and RVO mandates, (2) progress in Nutrition segment recovery, especially at Decatur East, and (3) the trajectory of North American agricultural exports and consumer demand for sweeteners and starches. Execution of cost reduction initiatives will also be a key performance marker.
Archer-Daniels-Midland currently trades at $67.53, in line with $68.08 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
| Mar-06 | |
| Mar-05 | |
| Feb-23 | |
| Feb-22 | |
| Feb-17 | |
| Feb-13 | |
| Feb-11 | |
| Feb-10 | |
| Feb-09 | |
| Feb-05 | |
| Feb-04 | |
| Feb-04 | |
| Feb-04 | |
| Feb-03 | |
| Feb-03 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite